BBBhaskar Birru

Bhaskar Birru

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Bhaskar Birru has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Nanobiotechnology Advances in Bioreactors for Biodiesel Production

    by Bhaskar Birru, P. Shalini, Madan L. Verma

    The global demand for energy has increased drastically along with the rapid increase in population and urbanization. The energy consumption is proportionally increasing with high economic growth. The worldwide trend resonates the manufacturing and servicing sector growth is increasing every year. The overall development in these two sectors pushes the growth index, which subsequently leads to higher energy consumption as per the reports of International Energy Outlook 2018 (IEO 2018). The energy consumption over the world is shown to increase from 1990 to 2040 in Figure 1. All countries over the world are classified into two categories based on their membership in the Organization for Economic and Cooperation Development (OECD). It was reported that population and economic growth rapidly growing in non-OECD countries had resulted in higher energy consumption. The sector-wise consumption of the world showed that the industrial sector accounts for higher energy consumption compared to transportation, building and other end-use sectors. As per the reports of IEO 2018, the energy consumption will increase drastically in all the sectors from 2020 to 2040. The fossil fuel depletion throughout the world is questing for alternative energy sources which primarily include energy obtained from water and wind, solar energy and biomass-derived energy. This has led to a focus on the third-generation of biofuels from algae biomass.


  • Stem Cells in Tumour Microenvironment Aid in Prolonged Survival Rate of Cancer Cells and Developed Drug Resistance: Major Challenge in Osteosarcoma Treatment

    by Bhaskar Birru, ChandraSai Potla Durthi, Santhosh Kacham, Madhuri Pola, Satish Babu Rajulapati, Sreenivasa Rao Parcha, Mohammad Amjad Kamal

    Osteosarcoma is an aggressive bone cancer found in children and adolescents. The combined treatment strategy includes the surgical removal of tumour and subsequent chemotherapy to prevent the reoccurrence has been a widely accepted approach. However, the drug resistance developed by tumour cells causes recurrence of cancer. It is imperative to understand the molecular mechanism involved in the development of drug resistance and tumour progression for developing potential therapy. Tumour microenvironment and cellular cross-talk via activation of various signalling pathways are responsible for tumour progression and metastasis. The comprehensive reviews are already available on the tumour microenvironment, signalling cascades responsible for tumour progression, and cellular crosstalk between malignant cells and immune cells. Therefore, we intend to provide comprehend review postulating the importance of mesenchymal stem cells (MSCs) in osteosarcoma progression and metastasis. This paper is aimed to provide information sequentially includes: tumour microenvironment, MSCs role in osteosarcoma progression, the hypoxic environment in MSCs recruitment at the tumour site and the importance of exosomes in tumorigenesis, progression and metastasis. Overall, this review may enlighten the research on the role of MSCs and MSCs derived exosome in osteosarcoma progression and drug resistance. This possibly may result in developing novel therapeutic approaches to combat the osteosarcoma effectively and contributes for the development of prognosis tools for early diagnosis.


  • Mechanistic role of perfusion culture on bone regeneration

    by Bhaskar Birru, Naveen Kumar Mekala, Sreenivasa Rao Parcha

    Bone tissue engineering (BTE) aims to develop engineered bone tissue to substitute conventional bone grafts. To achieve this, culturing the cells on the biocompatible three-dimensional (3D) scaffold is one alternative approach. The new functional bone tissue regeneration could be feasible by the synergetic combinations of cells, biomaterials and bioreactors. Although the field of biomaterial design/development for BTE applications attained reasonable success, development of suitable bioreactor remains still a major challenge. Tissue engineering bioreactors provide the microenvironment required for neo-tissue regeneration, and also can be used to study the physio-chemical cues effect on cell proliferation and differentiation in order to produce functional tissue. In this direction, various bioreactors have been developed and evaluated for the successful development of engineered bone tissue. Continues assessment of tissue development and limitations of the bioreactors lead to the progression of perfusion flow bioreactor system. Improvements in perfusion reactor system were able to yield multiple tissue engineered constructs with uniform cell distribution, easy to operate protocols and also effectively handled for the functional tissue development to meet the adequate supply of engineered graft for clinical application.


  • Open Access

    Improved osteogenic differentiation of umbilical cord blood MSCs using custom made perfusion bioreactor

    by Bhaskar Birru, Naveen Kumar Mekala, Sreenivasa Rao Parcha


  • Top Cited Papers

    PCL-Based Composite Scaffold Matrices for Tissue Engineering Applications

    by Nadeem Siddiqui, Simran Asawa, Bhaskar Birru, Ramaraju Baadhe, Sreenivasa Rao

    Biomaterial-based scaffolds are important cues in tissue engineering (TE) applications. Recent advances in TE have led to the development of suitable scaffold architecture for various tissue defects. In this narrative review on polycaprolactone (PCL), we have discussed in detail about the synthesis of PCL, various properties and most recent advances of using PCL and PCL blended with either natural or synthetic polymers and ceramic materials for TE applications. Further, various forms of PCL scaffolds such as porous, films and fibrous have been discussed along with the stem cells and their sources employed in various tissue repair strategies. Overall, the present review affords an insight into the properties and applications of PCL in various tissue engineering applications.


  • Composite porous scaffold of PEG/PLA support improved bone matrix deposition in vitro compared to PLA‐only scaffolds

    by Birru Bhaskar, Robert Owen, Hossein Bahmaee, Zena Wally, Parcha Sreenivasa Rao, Gwendolen C. Reilly

    Controllable pore size and architecture are essential properties for tissue‐engineering scaffolds to support cell ingrowth colonization. To investigate the effect of polyethylene glycol (PEG) addition on porosity and bone‐cell behavior, porous polylactic acid (PLA)–PEG scaffolds were developed with varied weight ratios of PLA–PEG (100/0, 90/10, 75/25) using solvent casting and porogen leaching. Sugar 200–300 µm in size was used as a porogen. To assess scaffold suitability for bone tissue engineering, MLO‐A5 murine osteoblast cells were cultured and cell metabolic activity, alkaline phosphatase (ALP) activity and bone‐matrix production determined using (alizarin red S staining for calcium and direct red 80 staining for collagen). It was found that metabolic activity was significantly higher over time on scaffolds containing PEG, ALP activity and mineralized matrix production were also significantly higher on scaffolds containing 25% PEG. Porous architecture and cell distribution and penetration into the scaffold were analyzed using SEM and confocal microscopy, revealing that inclusion of PEG increased pore interconnectivity and therefore cell ingrowth in comparison to pure PLA scaffolds. The results of this study confirmed that PLA–PEG porous scaffolds support mineralizing osteoblasts better than pure PLA scaffolds, indicating they have a high potential for use in bone tissue engineering applications. © 2018 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 106A: 1334–1340, 2018.


  • Design and Assessment of a Dynamic Perfusion Bioreactor for Large Bone Tissue Engineering Scaffolds

    by Birru Bhaskar, Robert Owen, Hossein Bahmaee, Parcha Sreenivasa Rao, Gwendolen C. Reilly

    Bioreactors can be used to apply fluid flow in vitro to scaffolds to improve mass transport of media and apply mechanical forces to cells. In this study, we developed and tested an autoclavable, modular perfusion bioreactor suitable for large scaffolds. We investigated the effects of fluid flow induced shear stress (FFSS) on osteogenic differentiation of human embryonic stem cell-derived mesenchymal progenitors (hES-MP cells) cultured on large polyurethane (PU) scaffolds (30 mm diameter × 5 mm thickness) in osteogenesis induction media (OIM). After seeding, scaffolds were either maintained in static conditions or transferred to the bioreactor 3 days post-seeding and a continuous flow rate of 3.47 mL/min was applied. Alkaline phosphatase activity (ALP) was used to evaluate osteogenic differentiation and resazurin salt reduction (RR) to measure metabolic activity after 10 days. Cultures subjected to flow contained significantly more metabolically active cells and higher total DNA content, as well as significantly higher ALP activity compared to scaffolds grown in static culture. These results confirm the responsiveness of hES-MP cells to fluid flow stimuli, and present a cost-effective, user-friendly bioreactor capable of supporting the growth and differentiation of mesenchymal progenitor cells within scaffolds capable of filling large bone defects.


  • Role of Signaling Pathways in Mesenchymal Stem Cell Differentiation

    by Birru Bhaskar, Naveen Kumar Mekala, Rama Raju Baadhe, Parcha Sreenivasa Rao

    Mesenchymal Stem Cells (MSCs) are self-renewing cells with ability to differentiate into organized, functional network of cells. In recent past research in developing clinical applications for MSCs has increased significantly. MSCs exhibit multi potential proliferation, and are capable of differentiating into cartilage, bone, neuronal cells and adipocytes, etc. Signaling pathways, transcription factors and growth factors modulate the differentiation of MSCs into different cell lineages. Besides, physical factors may regulate the molecular differentiation of stem cells. The main theme of this paper is to review the signaling pathways related to bone morphogenetic proteins (BMPs), epidermal growth factors (EGF), transforming growth factors (TGF), wingless type MMTV integration site (wnt) proteins, fibroblastic growth factor (FGF), and transcriptional regulating factors significance in the MSCs differentiation.